Scott D Solomon
Overview
Explore the profile of Scott D Solomon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
1198
Citations
55944
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Docherty K, McDowell K, Welsh P, Petrie M, Anand I, Berg D, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088234
Background: Inflammation may play an important pathophysiological role in the development and progression of heart failure (HF). Interleukin (IL)-6 is a circulating cytokine and is the main regulator of the...
2.
Kondo T, Jhund P, Anand I, Claggett B, Desai A, Docherty K, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088233
Background: Recent trials of new heart failure (HF) treatments suggest the effect of therapy may vary by N-terminal pro-B type natriuretic peptide (NT-proBNP) level. Objectives: The authors examined the efficacy...
3.
Davis B, Volk H, Nguyen O, Kamna D, Chen H, Barriales-Villa R, et al.
J Am Heart Assoc
. 2025 Mar;
:e038758.
PMID: 40055855
Background: Cardiac myosin inhibitors were recently developed to address the underlying pathophysiology of hypertrophic cardiomyopathy and to improve symptoms and quality of life. In this review, we evaluated the pharmacologic...
4.
Johansen N, Bhatt A, Claggett B, Dueger E, Solomon S, Vaduganathan M, et al.
JAMA Netw Open
. 2025 Mar;
8(3):e250320.
PMID: 40053354
No abstract available.
5.
Masini G, Wang W, Ji Y, Eaton A, Inciardi R, Soliman E, et al.
Stroke
. 2025 Mar;
PMID: 40052267
Background: Various measures of abnormal left atrial (LA) structure or function (LA myopathy) are associated with a higher risk of ischemic stroke and dementia, independent of atrial fibrillation. However, limited...
6.
Inciardi R, Lu H, Claggett B, Desai A, Jhund P, Lam C, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40047763
Background: Patients with severe heart failure (HF) experience debilitating clinical symptoms and worse cardiovascular (CV) outcomes with an excess mortality risk. Objectives: The authors aimed to assess the prevalence, CV...
7.
McDowell K, Docherty K, Campbell R, Henderson A, Jhund P, Claggett B, et al.
JAMA Cardiol
. 2025 Mar;
PMID: 40042880
Importance: Patients with heart failure (HF) and mildly reduced ejection fraction (HFmrEF) or preserved ejection fraction (HFpEF) have a spectrum of risk, and the effect of therapies may vary by...
8.
Yang M, Kondo T, Dewan P, Desai A, Lam C, Lefkowitz M, et al.
Circ Heart Fail
. 2025 Mar;
:e011598.
PMID: 40026147
Background: How different combinations of comorbidities influence risk at the patient level and population level in patients with heart failure with mildly reduced ejection fraction/heart failure with preserved ejection fraction...
9.
Ostrominski J, Claggett B, Miao Z, Filippatos G, Desai A, Jhund P, et al.
Diabetes Care
. 2025 Feb;
PMID: 40019856
Objective: To evaluate the efficacy and safety of finerenone, a nonsteroidal mineralocorticoid receptor antagonist, in individuals with type 2 diabetes (T2D) and either chronic kidney disease (CKD) or heart failure...
10.
Cunningham J, Chatur S, Claggett B, Vaduganathan M, Desai A, Jhund P, et al.
JAMA Cardiol
. 2025 Feb;
PMID: 40009358
Importance: Worsening heart failure (HF) is commonly managed in the outpatient setting with adjustments in oral diuretic therapy. The effect of the nonsteroidal mineralocorticoid receptor antagonist finerenone on outpatient worsening...